Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9
Pharmacological treatment for substance use disorder: A systematic review
Joaquín Mateu-Mollá, Bartolomé Pérez Gálvez, Víctor José Villanueva‐Blasco
Addictive Behaviors (2025) Vol. 163, pp. 108242-108242
Closed Access | Times Cited: 1
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings
Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, et al.
Frontiers in Human Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review
Charlotte Goldfine, Jeremiah J. Tom, Dana D. Im, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 14
Management of alcohol withdrawal syndromes in general hospital settings
Kristopher A. Kast, S. Alex Sidelnik, Shamim H. Nejad, et al.
BMJ (2025), pp. e080461-e080461
Closed Access
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study
Antoine Elyn, Anne Roussin, C. Lestrade, et al.
Regional Anesthesia & Pain Medicine (2024), pp. rapm-105035
Closed Access | Times Cited: 3
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
E.M. Van Gent, J. Bryan, M Cleary, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 541-550
Open Access | Times Cited: 3
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Four good reasons to choose ketamine in the emergency department. A case series and literature review
Fabiana Belviso, Erika Poggiali, Eva Ioannilli, et al.
Emergency Care Journal (2024)
Open Access | Times Cited: 1
Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports
Jocelyn Lee, Nitin Chopra, Tianna Costa, et al.
The American Journal of Drug and Alcohol Abuse (2024) Vol. 50, Iss. 3, pp. 426-427
Open Access | Times Cited: 1
Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature
Gianmarco Ingrosso, Anthony J. Cleare, Mário F. Juruena
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 1
No time to lose: the current state of research in rapid-acting psychotherapeutics
Joshua A. Gordon, Nora D. Volkow, George F. Koob
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 10-14
Closed Access | Times Cited: 3
High-Throughput Assay of Cytochrome P450-Dependent Drug Demethylation Reactions and Its Use to Re-evaluate the Pathways of Ketamine Metabolism
Nadezhda Y. Davydova, David A. Hutner, Kari A. Gaither, et al.
(2023)
Open Access | Times Cited: 3
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Nicolas Garel, Kyle T. Greenway, Lê-Anh Dinh-Williams, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1769-1777
Open Access | Times Cited: 3
Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report
Florence Jaguga, Philip Kirwa, Benson N. Gakinya, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder
Dale Terasaki
Psychedelic Medicine (2024) Vol. 2, Iss. 2, pp. 116-126
Closed Access
Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline
Kannapiran Ponraj, Kari A. Gaither, Dilip Kumar Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline
Kannapiran Ponraj, Kari A. Gaither, Dilip Kumar Singh, et al.
Biochemical Pharmacology (2024) Vol. 230, pp. 116569-116569
Open Access
Renaissance of Ketamine
Kinga Kocur, Katarzyna Camlet, Anna Ziobro, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 156-163
Open Access
High-Throughput Assay of Cytochrome P450-Dependent Drug Demethylation Reactions and Its Use to Re-Evaluate the Pathways of Ketamine Metabolism
Nadezhda Y. Davydova, David A. Hutner, Kari A. Gaither, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1055-1055
Open Access | Times Cited: 1
Intérêt et mécanismes d’action de la kétamine dans le traitement de l’addiction à l’alcool – Revue des études cliniques et précliniques
Fahd François Hilal, Jérôme Jeanblanc, Mickaël Naassïla
Biologie Aujourd hui (2023) Vol. 217, Iss. 3-4, pp. 161-182
Closed Access | Times Cited: 1
The Incidental Resolution of Severe Alcohol Use Disorder during Esketamine Treatment of Major Depressive Disorder: A Case Report
Zeeshan Faruqui, Christopher Kim
Case Reports in Psychiatry (2022) Vol. 2022, pp. 1-4
Open Access | Times Cited: 1
New Frontiers in Ketamine Research: From Mechanisms of Action to Novel Psychiatric Treatment Approaches
Marcus C. Rosenhagen, Julien Elowe, Alberto Forte, et al.
American Journal of Psychiatry and Neuroscience (2023)
Open Access
Page 1

Scroll to top